Photodynamic diagnosis by LED endoscopy system

Phase 2

Recruiting

• Conditions: Alimentary canal tumor

• Registration Number: JPRN-jRCTs061200034
• Lead Sponsor: Isomoto Hajime

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-12-07
• Last Update Posted: 2023-10-17

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1) 18 or above years old male or female
2) Patients who undergo endoscopic examination (criteria 1) or treatment (criteria 2) for gastrointestinal tumor
Criteria 1: Patients with (Including suspected symptoms) colitic cancer or DALM (dysplasia-associated lesions or mass) related to inflammatory bowel disease
Criteria 2: Patients with (Including suspected symptoms) esophageal tumor, gastric tumor, duodenal tumor or colon tumor
3) Patients with ECOG Performance Status 0 or 1
4) Patients with preserved heart, lung, liver and kidney function
5) Patients who received written consent from the study subject. For below the age of 20, patients who have also obtained consent from their legal representatives.

Exclusion Criteria

1) Patients with a history of hypersensitivity to 5-ALA or porphyrin
2) Porphyria patients
3) Patients who need to take medicines or foods known to cause photosensitivity from admission to 14 days postdose.
4) Patients with absolute contraindications to gastrointestinal endoscopy
5) Pregnant women or patients who may be pregnant
6) Patients who cannot ingest
7) Patients who cannot be properly shielded 48 hours postdose
8) Patients who received drug treatment for malignant tumor within 1 month before obtaining consent
9) Patients who received study drug within 3 months before study drug administration

Study & Design

• Study Type: Interventional
• Study Design: Not specified